88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking HONG KONG , Aug. 27, 2026 /PRNewswire/ -- As a premier global landmark in biotech, BIOHK2026 convenes international biotech hubs, cross-disciplinary industry forums, and high-impact networking events ... 2026-08-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nature Biotechnology \| Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result SHANGHAI and LAGUNA HILLS, Calif. , Aug. 27, 2026 /PRNewswire/ -- The complete results of AIntibody, the first international AI antibody design competition, have now been formally published in Nature ... 2026-08-27T Biotechnology Medical/Pharmaceuticals
Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta BUENOS AIRES, Argentina , Aug. 27, 2026 /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, ... 2026-08-27T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth Results Highlights for Interim Results ended 30 June 2026 Revenue reached RMB1,006.5 million, increasing by 21.0% YoY Gross profit amounted to RMB341.7 million, increasing by 0.7% YoY Gross profit ... 2026-08-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company's SBTi-approved decarbonisation journey ... 2026-08-26T Biotechnology Environmental Products & Services Green Technology Health Care/Hospital
ReviR Therapeutics Receives FDA Rare Pediatric Disease Designation for RTX-117 in Charcot-Marie-Tooth Disease Designation supports the global development of RTX-117 and may provide potential future access to a transferable Priority Review Voucher, subject to approval and applicable requirements ... 2026-08-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically target—the multiple, co-existing cancer cell states that drive resistance in pancreatic ... 2026-08-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays SEATTLE and RICHMOND, BC , Aug. 26, 2026 /PRNewswire/ -- Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. ... 2026-08-26T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Alebund Pharmaceuticals Announces 2026 Interim Results SHANGHAI , Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today ... 2026-08-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
China's BCI Race Accelerates: Gestala Raises US$84 Million in Six Months SHANGHAI and CHENGDU, China , Aug. 26, 2026 /PRNewswire/ -- Gestala officially launched on January 1, 2026. Six months later, the company had completed two financing rounds totaling RMB 570 million, ... 2026-08-26T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved